Jessica S Donington

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. ncbi request reprint The role of surgery in the treatment of stage III non-small-cell lung cancer
    Amy E Gallo
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Falk CVRB, Stanford, CA 94303, USA
    Curr Oncol Rep 9:247-54. 2007
  2. doi request reprint Surgical approach to locally advanced non-small cell lung cancer
    Jessica S Donington
    NYU School of Medicine, New York, NY 10016, USA
    Cancer J 19:217-21. 2013
  3. doi request reprint Current readings: sublobar resection for non-small-cell lung cancer
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, New York, New York 10016, USA
    Semin Thorac Cardiovasc Surg 25:22-9. 2013
  4. doi request reprint American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer
    Jessica Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, New York, NY 10016, USA
    Chest 142:1620-35. 2012
  5. doi request reprint The WTS report on the current status of women in cardiothoracic surgery
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, New York, New York 10016, USA
    Ann Thorac Surg 94:452-8; discussion 458-9. 2012
  6. doi request reprint Management of early stage non-small cell lung cancer in high-risk patients
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, 530 1st Avenue, Suite 9V, New York, NY 10016, USA
    Thorac Surg Clin 22:55-65, vi. 2012
  7. doi request reprint Novel therapies for non-small cell lung cancer
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, 530 1st Ave, Suite 9V, New York, NY 10016, USA
    J Thorac Imaging 26:175-85. 2011
  8. doi request reprint Sex and gender differences in non-small cell lung cancer
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, New York, New York 10016, USA
    Semin Thorac Cardiovasc Surg 23:137-45. 2011
  9. ncbi request reprint Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior
    Chandra Goparaju
    Department of Thoracic and Cardiovascular Surgery, New York University Langone Medical Center, New York, NY 10016, USA
    J Thorac Oncol 8:1203-11. 2013
  10. pmc Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer
    Justin D Blasberg
    New York University School of Medicine, Department of Cardiothoracic Surgery, 530 First Ave, Suite 9V, New York, NY 10016 USA
    J Clin Oncol 28:936-41. 2010

Collaborators

Detail Information

Publications17

  1. ncbi request reprint The role of surgery in the treatment of stage III non-small-cell lung cancer
    Amy E Gallo
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, Falk CVRB, Stanford, CA 94303, USA
    Curr Oncol Rep 9:247-54. 2007
    ..In addition, the ability to sterilize mediastinal lymph nodes with induction therapy correlates strongly with survival following resection, but the ideal induction regime that balances the safety and efficacy has yet to be determined...
  2. doi request reprint Surgical approach to locally advanced non-small cell lung cancer
    Jessica S Donington
    NYU School of Medicine, New York, NY 10016, USA
    Cancer J 19:217-21. 2013
    ..Significant controversy exists regarding which patients with potentially resectable N2 should receive surgery and how to best integrate a resection with chemotherapy and radiation...
  3. doi request reprint Current readings: sublobar resection for non-small-cell lung cancer
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, New York, New York 10016, USA
    Semin Thorac Cardiovasc Surg 25:22-9. 2013
    ....
  4. doi request reprint American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer
    Jessica Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, New York, NY 10016, USA
    Chest 142:1620-35. 2012
    ..Unfortunately, up to 25% of patients with stage I NSCLC are not candidates for lobectomy because of severe medical comorbidity...
  5. doi request reprint The WTS report on the current status of women in cardiothoracic surgery
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, New York, New York 10016, USA
    Ann Thorac Surg 94:452-8; discussion 458-9. 2012
    ....
  6. doi request reprint Management of early stage non-small cell lung cancer in high-risk patients
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, 530 1st Avenue, Suite 9V, New York, NY 10016, USA
    Thorac Surg Clin 22:55-65, vi. 2012
    ..While these treatments appear to have decreased peri-procedural morbidity and mortality, their oncologic efficacy compared to that of lobectomy remains to be determined...
  7. doi request reprint Novel therapies for non-small cell lung cancer
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, 530 1st Ave, Suite 9V, New York, NY 10016, USA
    J Thorac Imaging 26:175-85. 2011
    ..Each of these advanced modalities works best for only a small subset of the population with lung cancer, and efficacious use is highly dependent on appropriate patient selection...
  8. doi request reprint Sex and gender differences in non-small cell lung cancer
    Jessica S Donington
    Department of Cardiothoracic Surgery, NYU School of Medicine, New York, New York 10016, USA
    Semin Thorac Cardiovasc Surg 23:137-45. 2011
    ....
  9. ncbi request reprint Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior
    Chandra Goparaju
    Department of Thoracic and Cardiovascular Surgery, New York University Langone Medical Center, New York, NY 10016, USA
    J Thorac Oncol 8:1203-11. 2013
    ..This study describes the overexpression of Ephrin B2 receptor (EPHB2) in MM cell lines and tumors, and the effect of its manipulation on proliferative and invasive qualities of the disease...
  10. pmc Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer
    Justin D Blasberg
    New York University School of Medicine, Department of Cardiothoracic Surgery, 530 First Ave, Suite 9V, New York, NY 10016 USA
    J Clin Oncol 28:936-41. 2010
    ..CONCLUSION Plasma OPN levels are elevated in early-stage NSCLC. They are reduced after resection and appear to increase with recurrence. Plasma OPN may have utility as a biomarker in early-stage NSCLC...
  11. pmc Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer
    Chandra M V Goparaju
    Department of Cardiothoracic Surgery, New York University School of Medicine, New York City, New York 10016, USA
    J Thorac Oncol 5:1516-23. 2010
    ..Moreover, the role of the three known mRNA isoforms (OPNa, OPNb, and OPNc) has not been reported. We hypothesize that OPN isoforms play different roles in determining the metastatic potential of NSCLC...
  12. pmc Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity
    Justin D Blasberg
    Department of Cardiothoracic Surgery, New York University School of Medicine, New York, NY 10016, USA
    J Thorac Cardiovasc Surg 139:1587-93. 2010
    ..We hypothesize that osteopontin isoforms (OPNa, OPNb, and OPNc) have divergent roles in non-small-cell lung cancer angiogenesis and divergent impact on vascular endothelial growth factor secretion...
  13. doi request reprint Initial experience with endobronchial ultrasound in an academic thoracic surgery program
    Costas S Bizekis
    Division of Thoracic Surgery, Department of Cardiothoracic Surgery, New York University Langone Medical Center, USA
    Clin Lung Cancer 11:25-9. 2010
    ..Recent literature found an early learning curve for this technique. We present the initial experience of 4 thoracic surgeons with the procedure...
  14. ncbi request reprint Sublobar resection: a movement from the Lung Cancer Study Group
    Justin D Blasberg
    Department of Surgery, St Luke s Roosevelt Medical Center, New York, NY, USA
    J Thorac Oncol 5:1583-93. 2010
    ..This review summarizes the literature from the past 15 years to assist in applying those conclusions to future research innovation...
  15. doi request reprint Simulating video-assisted thoracoscopic lobectomy: a virtual reality cognitive task simulation
    Brian Solomon
    Department of Cardiothoracic Surgery, New York University School of Medicine, New York, NY, USA
    J Thorac Cardiovasc Surg 141:249-55. 2011
    ..In response, we hypothesized that video-assisted thoracoscopic surgery right upper lobe resection could be simulated in a virtual reality environment with commercial software...
  16. doi request reprint Infections and radiation injuries involving the chest wall
    Justin D Blasberg
    Department of General Surgery, St Luke s Roosevelt Medical Center, Columbia University College of Physicians and Surgeons, 1000 Tenth Avenue, Suite 2B, New York, NY 10023, USA
    Thorac Surg Clin 20:487-94. 2010
    ..This article addresses the risk factors, pathophysiology, clinical presentation, and management of chest wall and sternoclavicular joint infections, necrotizing processes, and radiation injury...
  17. ncbi request reprint Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response
    Jessica S Donington
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, CA 94303, USA
    Clin Lung Cancer 8:22-9. 2006
    ..Several phase II trials with small-molecule inhibitors of Src are under way or have been initiated in lung cancer and in other malignancies, as discussed herein...